Biliverdin reductase isozymes in metabolism

Luke O'Brien, Peter Hosick, Kezia John, David E. Stec, Terry D. Hinds

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

The biliverdin reductase (BVR) isozymes BVRA and BVRB are cell surface membrane receptors with pleiotropic functions. This review compares, for the first time, the structural and functional differences between the isozymes. They reduce biliverdin, a byproduct of heme catabolism, to bilirubin, display kinase activity, and BVRA, but not BVRB, can act as a transcription factor. The binding motifs present in the BVR isozymes allow a wide range of interactions with components of metabolically important signaling pathways such as the insulin receptor kinase cascades, protein kinases (PKs), and inflammatory mediators. In addition, serum bilirubin levels have been negatively associated with abdominal obesity and hypertriglyceridemia. We discuss the roles of the BVR isozymes in metabolism and their potential as therapeutic targets.

Original languageEnglish
Pages (from-to)212-220
Number of pages9
JournalTrends in Endocrinology and Metabolism
Volume26
Issue number4
DOIs
StatePublished - 1 Jan 2015

Fingerprint

biliverdin reductase
Isoenzymes
Bilirubin
Phosphotransferases
Biliverdine
Abdominal Obesity
Hypertriglyceridemia
Insulin Receptor
Cell Surface Receptors
Heme
Protein Kinases
Transcription Factors
Cell Membrane
Serum

Keywords

  • BVRA
  • BVRB
  • Bilirubin
  • Biliverdin reductase
  • Diabetes
  • Heme oxygenase
  • Obesity

Cite this

O'Brien, Luke ; Hosick, Peter ; John, Kezia ; Stec, David E. ; Hinds, Terry D. / Biliverdin reductase isozymes in metabolism. In: Trends in Endocrinology and Metabolism. 2015 ; Vol. 26, No. 4. pp. 212-220.
@article{5c3b7c0c6b804073986ab47ade80fc09,
title = "Biliverdin reductase isozymes in metabolism",
abstract = "The biliverdin reductase (BVR) isozymes BVRA and BVRB are cell surface membrane receptors with pleiotropic functions. This review compares, for the first time, the structural and functional differences between the isozymes. They reduce biliverdin, a byproduct of heme catabolism, to bilirubin, display kinase activity, and BVRA, but not BVRB, can act as a transcription factor. The binding motifs present in the BVR isozymes allow a wide range of interactions with components of metabolically important signaling pathways such as the insulin receptor kinase cascades, protein kinases (PKs), and inflammatory mediators. In addition, serum bilirubin levels have been negatively associated with abdominal obesity and hypertriglyceridemia. We discuss the roles of the BVR isozymes in metabolism and their potential as therapeutic targets.",
keywords = "BVRA, BVRB, Bilirubin, Biliverdin reductase, Diabetes, Heme oxygenase, Obesity",
author = "Luke O'Brien and Peter Hosick and Kezia John and Stec, {David E.} and Hinds, {Terry D.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.tem.2015.02.001",
language = "English",
volume = "26",
pages = "212--220",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "4",

}

Biliverdin reductase isozymes in metabolism. / O'Brien, Luke; Hosick, Peter; John, Kezia; Stec, David E.; Hinds, Terry D.

In: Trends in Endocrinology and Metabolism, Vol. 26, No. 4, 01.01.2015, p. 212-220.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Biliverdin reductase isozymes in metabolism

AU - O'Brien, Luke

AU - Hosick, Peter

AU - John, Kezia

AU - Stec, David E.

AU - Hinds, Terry D.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The biliverdin reductase (BVR) isozymes BVRA and BVRB are cell surface membrane receptors with pleiotropic functions. This review compares, for the first time, the structural and functional differences between the isozymes. They reduce biliverdin, a byproduct of heme catabolism, to bilirubin, display kinase activity, and BVRA, but not BVRB, can act as a transcription factor. The binding motifs present in the BVR isozymes allow a wide range of interactions with components of metabolically important signaling pathways such as the insulin receptor kinase cascades, protein kinases (PKs), and inflammatory mediators. In addition, serum bilirubin levels have been negatively associated with abdominal obesity and hypertriglyceridemia. We discuss the roles of the BVR isozymes in metabolism and their potential as therapeutic targets.

AB - The biliverdin reductase (BVR) isozymes BVRA and BVRB are cell surface membrane receptors with pleiotropic functions. This review compares, for the first time, the structural and functional differences between the isozymes. They reduce biliverdin, a byproduct of heme catabolism, to bilirubin, display kinase activity, and BVRA, but not BVRB, can act as a transcription factor. The binding motifs present in the BVR isozymes allow a wide range of interactions with components of metabolically important signaling pathways such as the insulin receptor kinase cascades, protein kinases (PKs), and inflammatory mediators. In addition, serum bilirubin levels have been negatively associated with abdominal obesity and hypertriglyceridemia. We discuss the roles of the BVR isozymes in metabolism and their potential as therapeutic targets.

KW - BVRA

KW - BVRB

KW - Bilirubin

KW - Biliverdin reductase

KW - Diabetes

KW - Heme oxygenase

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84933673406&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2015.02.001

DO - 10.1016/j.tem.2015.02.001

M3 - Review article

C2 - 25726384

AN - SCOPUS:84933673406

VL - 26

SP - 212

EP - 220

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 4

ER -